GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC 50 s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively.
性状
Solid
IC50 & Target[1][2]
IC50: 2.3 nM (human KMO), 0.7 nM (Pf-KMO)
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Hutchinson JP, et al. Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nat Commun. 2017 Jun 12;8:15827.
溶解度数据
In Vitro: DMSO : 250 mg/mL (691.03 mM; Need ultrasonic)配制储备液
[1]. Hutchinson JP, et al. Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nat Commun. 2017 Jun 12;8:15827.